D-0800-2020 Class II Terminated
FDA drug recall D-0800-2020 was initiated by Tuscano and Delucia Group (DBA Entropic Labs) on August 24, 2019 and is designated Class II. Reason for recall: Marketed Without An Approved NDA/ANDA: product contains Selective Androgen Receptor Modulators (SARMs) The recall status is terminated (terminated July 12, 2023). Affected quantity: 60.
Recall Details
- Product Type
- Drugs
- Report Date
- January 29, 2020
- Initiation Date
- August 24, 2019
- Termination Date
- July 12, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 60
Product Description
Entropic Labs SARM RAD-140, 20mg Capsules, 30-count bottles, Entropic Labs UPC#: 651074545302
Reason for Recall
Marketed Without An Approved NDA/ANDA: product contains Selective Androgen Receptor Modulators (SARMs)
Distribution Pattern
Nationwide within the United States
Code Information
All lots